APA (7th ed.) Citation

Sardu, C., Sardu, C., Massetti, M., Massetti, M., Testa, N., Martino, L. D., . . . Marfella, R. (2021). Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Sardu, Celestino, et al. Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Sardu, Celestino, et al. Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up. Frontiers Media S.A, 2021.